InvestorsHub Logo
Followers 19
Posts 2069
Boards Moderated 0
Alias Born 11/03/2008

Re: sab63090 post# 446445

Saturday, 01/06/2024 12:28:20 PM

Saturday, January 06, 2024 12:28:20 PM

Post# of 462121
Bottom line the drug failed a primary endpoint for whatever reason justified or not. They will certainly go and get guidance from the FDA but stockholders or patients will not here anything about what they say except some vague answer. The company is going to do what they do regardless of what I think they should do. I have sold a significant portion of my shares and lack the confidence that Missling will ever be direct in communicating. Vote with your feet. This man may be a genius and is certainly much smarter than me but in my over 50 years of investing he is the least transparent communicator bordering on deception.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News